Liquid chromatography tandem mass spectrometry drug discovery

Hsieh Y. et al., 2000. Direct analysis of plasma samples for drug discovery compounds using mixed-function column liquid chromatography tandem mass spectrometry. Rapid Commun Mass Spectrom 14 1384. [Pg.295]

M. M. et al. Brain and plasma exposure profiling in early drug discovery using cassette administration and fast liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 2004, 34, 359-368. [Pg.424]

Korfmacher, W. A. Veals, J. Dunn-Meynell, K. Zhang, X. Tucker, G. et al. Demonstration of the capabilities of a parallel high performance liquid chromatography tandem mass spectrometry system for use in the analysis of drug discovery plasma samples. Rapid Commun Mass Spectrom 1999, 13, 1991-1998. [Pg.425]

Xu, X. Zhou, Q. Korfmacher, W. A. Development of a low volume plasma sample precipitation procedure for liquid chromatography/tandem mass spectrometry assays used for drug discovery applications. Rapid Commun Mass Spectrom 2005, 19, 2131-2136. [Pg.426]

Hsieh, Y., Chintala, M., Mei, H., Agans, J., Brisson, J. M., Ng, K., and Korfmacher, W. A. (2001). Quantitative screening and matrix effect studies of drug discovery compounds in monkey plasma [by] using fast-gradient liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 15 2481-2487. [Pg.118]

Larger, P. J., Breda, M., Lraier, D., Hughes, H., and James, C. A. (2005). Ion-suppression effects in liquid chromatography-tandem mass spectrometry due to a formulation agent, a case study in drug discovery bioanalysis. J. Pharm. Biomed. Anal. 39 206-216. [Pg.119]

Hsieh Y et al (2002) Direct cocktail analysis of drug discovery compounds in pooled plasma samples using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 767 353-362... [Pg.244]

Hsieh, Y Bryant, M.S. Gruela, G. Brisson, J.-M. Korfmacher, W.A. Direct Analysis of Plasma Samples for Drug Discovery Compounds Using Mixed-function Column Liquid Chromatography Tandem Mass Spectrometry, Rapid Commun. Mass Spectrom. 14, 1384-1390 (2000). [Pg.222]

K.A. Lin, C.C. Demonstration of the Capabilities of a Parallel High Performance Liquid Chromatography Tandem Mass Spectrometry System for Use in the Analysis of Drug Discovery Samples, Rapid Commun. Mass Spectrom. 13, 1991-1999 (1999). [Pg.355]

Wang, G. Hsieh, Y Lau, Y Cheng, K.C. Ng, K. Korfmacher,W.A. White, R.E. Semi-Automated Determination of Plasma Stability of Drug Discovery Compounds Using Liquid Chromatography-Tandem Mass Spectrometry, J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 780(2), 451 57 (2002). [Pg.375]

Chu I, Liu F, Soares A, Kumari P, Nomeir AA. Generic fast gradient liquid chromatography/ tandem mass spectrometry techniques for the assessment of the in vitro permeability across the blood-brain barrier in drug discovery Rapid Common Mass Spectrom 2002 16(15) 1501-1505. [Pg.161]

Yu S, Li S, Yang H, Lee F, Wu JT, Qian MG. A novel liquid chromatography/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discovery. Rapid Commun Mass Spectrom 2005b 19(2) 250-254. [Pg.167]

Mallett, D.N., Ramfrez-Molina, C. (2009) The use of partially porous particle columns for the routine, generic analyses of biological samples for pharmacokinetic studies in drug discovery by reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 49, 100-107. [Pg.206]

Beaudry F. et al., 1998. In vivo pharmacokinetic screening in cassette dosing experiments Use of online Pros-pekt liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry technology in drug discovery. Rapid Commun Mass Spectrom 12 1216. [Pg.293]